Aoxiang pharmaceutical is located in Linhai City, Zhejiang Province, 2013, the company was named high-tech enterprises. 2014 year, the company’s chemical pharmaceutical research and development center was named the provincial high-tech enterprise research and development center.
Our goal is not only to provide customers with the best medicine and chemical products, but also to create value for our customers.';
我們主要提供肝病、呼吸系統、心腦血管、高端氟產品、前列腺素產品和客戶訂制加工等服務。='We mainly provide liver disease, respiratory system, cardiovascular and cerebrovascular, high-end fluoride products, products and customer service, such as custom processing.
2013 to achieve sales of billion yuan; in 2014 is expected to achieve sales of yuan; 2015 is expected to achieve sales of , plans to issue stock by the end of 2016, is expected to reach 12 billion in 2020, the company’s market value.';
誠信、共贏是我們的基本戰略原則。='Honesty, mutual benefit is our basic strategic principles.
The company was founded in April 2010 and is headquartered in Zhejiang, Taizhou province. Shares of the company were listed on the Shanghai stock exchange in May 9, 2017. The shares were referred to as "Aoxiang pharmaceuticals" and the stock code "603229"". The company's main business is characterized by raw materials, pharmaceutical intermediates research and development, production and marketing, as well as to provide customers with customized processing and research and development business. Products with many chiral structure, research and development difficult, high technical barriers, unique production technology and so on. The company is a high-tech enterprise, has been identified as "provincial high-tech enterprise research and development center", "provincial enterprise institute", the company has academician workstation, post doctoral, postdoctoral innovation base and excellent development platform, with many universities and research institutes to maintain good cooperation.